BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3704541)

  • 1. Irreversible ototoxic effect of erythromycin.
    Levin G; Behrenth E
    Scand Audiol; 1986; 15(1):41-2. PubMed ID: 3704541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ototoxic effect of erythromycin therapy.
    Schweitzer VG; Olson NR
    Arch Otolaryngol; 1984 Apr; 110(4):258-60. PubMed ID: 6704042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxic reaction to erythromycin.
    Agustí C; Ferrán F; Gea J; Picado C
    Arch Intern Med; 1991 Feb; 151(2):380. PubMed ID: 1992966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin ototoxicity.
    Thompson P; Wood RP; Bergstrom L
    J Otolaryngol; 1980 Feb; 9(1):60-2. PubMed ID: 7359612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia.
    Swanson DJ; Sung RJ; Fine MJ; Orloff JJ; Chu SY; Yu VL
    Am J Med; 1992 Jan; 92(1):61-8. PubMed ID: 1731511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible sensorineural hearing loss due to erythromycin.
    Dylewski J
    CMAJ; 1988 Aug; 139(3):230-1. PubMed ID: 3395937
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.
    Wallach PM; Love SR; Fiorica JV; Hoffman MS; Flannery MT
    J Fla Med Assoc; 1992 Dec; 79(12):821-2. PubMed ID: 1474367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin ototoxicity: a call to heighten recognition.
    Whitener CJ; Parker JE; Lapp NL
    South Med J; 1991 Oct; 84(10):1214-6. PubMed ID: 1925722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naproxen-associated sudden sensorineural hearing loss.
    McKinnon BJ; Lassen LF
    Mil Med; 1998 Nov; 163(11):792-3. PubMed ID: 9819544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin ototoxicity and acute psychotic reaction in cancer patients with hepatic dysfunction.
    Umstead GS; Neumann KH
    Arch Intern Med; 1986 May; 146(5):897-9. PubMed ID: 3963982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reversible hearing loss and erythromycin].
    Rydberg J
    Lakartidningen; 1984 Mar; 81(13):1308. PubMed ID: 6708672
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report.
    Ress BD; Gross EM
    Ann Otol Rhinol Laryngol; 2000 Apr; 109(4):435-7. PubMed ID: 10778901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical perspectives on ototoxic drugs.
    Matz GJ
    Ann Otol Rhinol Laryngol Suppl; 1990 Jun; 148():39-41. PubMed ID: 2112362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensorineural hearing loss with low dose erythromycin.
    Kemp E; Keidar S; Brook JG
    BMJ; 1991 Jun; 302(6788):1341. PubMed ID: 2059706
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced aseptic meningitis, sensorineural hearing loss and vestibulopaty.
    Sepcić J; Bucuk M; Perković O; Sepić-Grahovac D; Troselj-Vukić B; Poljak I; Crnić-Martinović M; Turel I; Ristić S; Sepcić K
    Coll Antropol; 2010 Sep; 34(3):1101-4. PubMed ID: 20977110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin ototoxicity: analysis and conclusions based on 22 case reports.
    Haydon RC; Thelin JW; Davis WE
    Otolaryngol Head Neck Surg; 1984 Dec; 92(6):678-84. PubMed ID: 6440087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible sensorineural hearing loss: an unusual side effect of non-steroidal anti-inflammatory drugs.
    Ahmad S; Bhanji A; Pal S; Karim M
    Int J Clin Pharmacol Ther; 2010 Aug; 48(8):514-6. PubMed ID: 20650042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromycin-induced ototoxicity substantiated by rechallenge.
    Schwartz JI; Maggini GA
    Clin Pharm; 1982; 1(4):374-6. PubMed ID: 7185536
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ototoxic side effects in patients with ovarian cancer treated with cisplatin].
    Behling H; Spieske C; Krafft W
    Zentralbl Gynakol; 1988; 110(5):277-82. PubMed ID: 3376611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An updated guide on drugs inducing ototoxicity, tinnitus and vertigo].
    Cianfrone G; Pace M; Turchetta R; Cianfrone F; Altissimi G
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5 Suppl 81):3-31. PubMed ID: 16532796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.